1. Home
  2. MASS vs ACOG Comparison

MASS vs ACOG Comparison

Compare MASS & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MASS
  • ACOG
  • Stock Information
  • Founded
  • MASS 2012
  • ACOG 2000
  • Country
  • MASS United States
  • ACOG Canada
  • Employees
  • MASS N/A
  • ACOG N/A
  • Industry
  • MASS Medical/Dental Instruments
  • ACOG
  • Sector
  • MASS Health Care
  • ACOG
  • Exchange
  • MASS Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • MASS 84.3M
  • ACOG 80.3M
  • IPO Year
  • MASS 2020
  • ACOG N/A
  • Fundamental
  • Price
  • MASS $6.90
  • ACOG $10.80
  • Analyst Decision
  • MASS Buy
  • ACOG Strong Buy
  • Analyst Count
  • MASS 3
  • ACOG 1
  • Target Price
  • MASS $5.33
  • ACOG $20.00
  • AVG Volume (30 Days)
  • MASS 699.4K
  • ACOG 67.2K
  • Earning Date
  • MASS 08-05-2025
  • ACOG 08-14-2025
  • Dividend Yield
  • MASS N/A
  • ACOG N/A
  • EPS Growth
  • MASS N/A
  • ACOG N/A
  • EPS
  • MASS N/A
  • ACOG N/A
  • Revenue
  • MASS $63,986,000.00
  • ACOG $2,928,654.00
  • Revenue This Year
  • MASS N/A
  • ACOG N/A
  • Revenue Next Year
  • MASS $22.44
  • ACOG N/A
  • P/E Ratio
  • MASS N/A
  • ACOG N/A
  • Revenue Growth
  • MASS 32.85
  • ACOG N/A
  • 52 Week Low
  • MASS $1.81
  • ACOG $3.75
  • 52 Week High
  • MASS $8.06
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • MASS 53.47
  • ACOG N/A
  • Support Level
  • MASS $6.33
  • ACOG N/A
  • Resistance Level
  • MASS $7.27
  • ACOG N/A
  • Average True Range (ATR)
  • MASS 0.44
  • ACOG 0.00
  • MACD
  • MASS -0.05
  • ACOG 0.00
  • Stochastic Oscillator
  • MASS 45.60
  • ACOG 0.00

About MASS 908 Devices Inc.

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: